BOSTON--(BUSINESS WIRE)--Nov 3, 2025--

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that management will participate in the following upcoming investor conferences:

Guggenheim Securities 2 nd Annual Healthcare Innovation Conference (Boston, MA)

Monday, November 10, 2025 at 11:30 a.m. ET, Fireside Chat

Stifel 2025 Healthcare Conference (New York, NY)

Thursday, November 13, 2025 at 4:00 p.m. ET, Fireside Chat

A webcast of each conference presentation will be available on the "Events & Presentations" page within the Investors section of the PepGen website at https://investors.pepgen.com/ . Replay

See Full Page